44 results
Page 2 of 3
8-K
EX-10.1
y76 r7nin4mdck4eir6
9 Sep 20
Departure of Directors or Certain Officers
8:02am
8-K
EX-10.1
xwx 2zylfczx5yz1t3np
23 Mar 20
Departure of Directors or Certain Officers
7:31am
8-K
EX-99.2
9lyfm
24 Sep 19
Durability of Response Determined to be 89 Percent at Six Months and 84 Percent at 12 Months
5:20pm
10-Q
ycoa cwv8o32fdb
9 May 19
Quarterly report
7:13am
DEF 14A
bcr rmrbwv
26 Apr 19
Definitive proxy
5:00pm
10-K
7fd70oxi2mjxvyugn
28 Feb 19
Annual report
1:08pm
10-K
EX-10.13
mfy3vtldvsjgh
28 Feb 19
Annual report
1:08pm
10-K
EX-10.14
t3g eybh9
28 Feb 19
Annual report
1:08pm
424B5
3wzk8 s2i
25 Jan 19
Prospectus supplement for primary offering
8:01am
424B5
eapr3icvfd5
22 Jan 19
Prospectus supplement for primary offering
5:12pm
8-K
EX-99.2
kizuiu 2p51j6
22 Jan 19
UroGen Pharma Announces Proposed Public Offering of Ordinary Shares
5:08pm